Amylx Pharmaceuticals Inc vs NIO Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while NIO Inc. trades at $4.57 (market cap $11.59B). The key difference: NIO Inc. is far larger — about 4.4× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| AMLX | NIO | |
|---|---|---|
Market Cap | $2.64B | $11.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $7.89 |
52-Week Low | $7.82 | $4.44 |
Enterprise Value | $2.39B | $10.82B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →